Zobrazeno 1 - 10
of 176
pro vyhledávání: '"Lavaut Mn"'
Autor:
Sophie Giusiano, David Jérémie Birnbaum, Stéphane Garcia, Colette Charpin, Lavaut Mn, Véronique Secq, Pascal Bonnier, J. Villeret, Fattaneh A. Tavassoli, J. Iovanna
Publikováno v:
Cancer Research. 71:P4-09
Background Immunohistochemical (IHC) signatures predictive of prognosis can be a cost effective alternative to genomic signature suitable in clinical practice for patients’ management in early stages of breast carcinoma (BrCa) in clinical. IHC proc
Autor:
V Secq, Pascal Bonnier, S Charfi, Claude Allasia, Lucile Andrac, Sophie Giusiano, Colette Charpin, Séverine Carpentier, Lavaut Mn, Stéphane Garcia
Publikováno v:
British Journal of Cancer
Background: c Kit (CD117) expression in tissues has been reported as a relevant target for specific therapy in some human malignancies, but has been poorly documented in breast carcinomas Methods: The prognostic significance of c Kit in a series of 9
Autor:
Charpin-Taranger C, Claude Allasia, Charafe-Jauffret E, David Jérémie Birnbaum, Séverine Carpentier-Meunier, Jean-Philippe Dales, Pascal Bonnier, Lavaut Mn, Stéphane Garcia, Andrac-Meyer L, Jocelyne Jacquemier
Publikováno v:
British Journal of Cancer
Inflammatory breast carcinoma (IBC) is a rare but aggressive tumour associated with poor outcome owing to early metastases. Increased expression of c-Met protein correlates with reduced survival and high metastatic risk in human cancers including bre
Autor:
Claude Allasia, Lucile Andrac, Pascal Bonnier, C Taranger-Charpin, Séverine Carpentier, Lavaut Mn, Jean-Philippe Dales, O Ramuz, Stéphane Garcia
Publikováno v:
British Journal of Cancer
Neoangiogenesis in tumours contributes to the development of blood-borne metastases, and can be evaluated by markers of activated endothelial cells in preference to panendothelial markers. Our purpose was to document the prognostic significance of VE
Autor:
Stéphane Garcia, D Bergeret, Colette Charpin, Lavaut Mn, N Horschowski, R Choux, Lucile Andrac
Publikováno v:
British Journal of Cancer
VLA2 is thought to be involved in the metastatic process in malignant tumours, in particular in carcinomatous cell adhesion to vessel basement membrane. VLA2 expression was immunohistochemically investigated in 204 breast carcinomas. Frozen tissue se
Autor:
Lucile Andrac, Colette Charpin, C. Bouvier, Bénédicte Devictor, Claude Allasia, Stéphane Garcia, Lavaut Mn
Publikováno v:
British Journal of Cancer
Expression of the bcl-2 gene was investigated in 218 human breast carcinomas by immunohistochemical analysis. Immunodetections were assessed using (1) frozen sections, (2) documented commercially available monoclonal antibody (bcl-2/124, Dako), (3) a
Autor:
C. Bouvier, Lavaut Mn, Pascal Bonnier, Claude Allasia, Stéphane Garcia, Lucile Andrac, F Martini, Colette Charpin
Publikováno v:
British Journal of Cancer
The prognostic significance of c-erbB-2 oncoprotein overexpression detected in tumours by immunocytochemical assays (ICAs) was investigated in 148 breast carcinomas. ICAs were performed under optimal technical conditions with frozen tissue sections a
Autor:
Bénédicte Devictor, Colette Charpin, Lucile Andrac, Stéphane Garcia, Régine Choux, C. Bouvier, Lavaut Mn
Publikováno v:
The Journal of Pathology. 181:294-300
The reduction of E-cadherin expression, which is involved in the initial step of invasion and metastasis of cancer, was investigated in 218 human breast carcinomas. Quantitative immunohistochemical assays (ICAs) were performed on frozen sections. Qua
Autor:
Lucien Piana, Bénédicte Devictor, Nicole Horschowski, Denise Bergeret, Lavaut Mn, Colette Charpin, Lucile Andrac, Joelle Boulat
Publikováno v:
American Journal of Clinical Pathology. 103:443-448
The distribution of PECAM-1/CD31 molecule was investigated in 133 breast carcinomas using monoclonal antibody and frozen sections. Anti-CD31 labels endothelial cells and reflects stromal angiogenesis. The CD31 immunoreactivity was evaluated by comput
Autor:
Claude Allasia, Piana L, Lavaut Mn, N. Horschowski, Lucile Andrac, F. Duffaud, Devictor B, P. Vielh, Colette Charpin
Publikováno v:
JNCI Journal of the National Cancer Institute. 86:1539-1545
BACKGROUND Chemotherapy failure that is due to cellular drug resistance remains a major problem in most cancer patients. One type of drug resistance that has been characterized is the multidrug resistance phenomenon, which demonstrates a reduced abil